Viridian Therapeutics to Participate in Upcoming Investor Conferences
2021年5月14日 - 9:00PM
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical
company advancing new treatments for patients suffering from
serious diseases but underserved by today’s therapies, today
announced that Jonathan Violin, Ph.D., President and Chief
Executive Officer of Viridian, will present a company overview at
the virtual Oppenheimer Rare & Orphan Disease Summit and
participate in a fireside chat at the Jefferies Virtual Healthcare
Conference.
Event: |
Oppenheimer Rare & Orphan Disease Summit |
Date: |
Friday, May 21ST |
Presentation Time: |
9:05 a.m. ET |
|
|
Event: |
Jefferies Virtual Healthcare Conference |
Date: |
Tuesday, June 1ST |
Fireside Chat Time: |
11:30 a.m. ET |
Webcast information for these events will be accessible on the
Events page under the Investors section of the Viridian
Therapeutics website at www.viridiantherapeutics.com. A replay
of both the presentation and fireside chat will be archived on the
website and available for approximately 90 days following each live
event.
About Viridian Therapeutics
Viridian Therapeutics is a biotechnology company advancing new
treatments for patients suffering from serious diseases but
underserved by today’s therapies. Viridian’s most advanced program,
VRDN-001, is an anti-IGF-1R monoclonal antibody in development for
TED, a debilitating auto-immune disease that causes inflammation
and fibrosis within the orbit of the eye which can cause double
vision, pain, and potential blindness. Patients with severe disease
often require multiple remedial surgeries to the orbit, eye
muscles, and eyelids. Viridian is based in Boulder, Colorado, and
Waltham, Massachusetts. Learn more about Viridian and its programs
at https://www.viridiantherapeutics.com/.
Follow us on Twitter @ViridianThera and on LinkedIn.
Viridian
Contacts:Investors:Dan FerryLifeSci
Advisors617-430-7576IR@viridiantherapeutics.com
Media:Darby PearsonVerge Scientific
Communications703-587-0831PR@viridiantherapeutics.com
Viridian Therapeutics (NASDAQ:VRDN)
過去 株価チャート
から 6 2024 まで 7 2024
Viridian Therapeutics (NASDAQ:VRDN)
過去 株価チャート
から 7 2023 まで 7 2024